Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III

RecruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 28, 2026

Study Completion Date

December 28, 2026

Conditions

Lymphoma, Non-HodgkinLymphoma, Hodgkin

Interventions

DRUG

Chemotherapy

Systemic chemotherapy with curative intent

Trial Locations (1)

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors

collaborator

Samsung Genomic Institute

UNKNOWN

lead

Samsung Medical Center

OTHER